IMMUCOR INC
10-Q, EX-27, 2001-01-16
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: IMMUCOR INC, 10-Q, EX-2, 2001-01-16
Next: ALLIANCE PHARMACEUTICAL CORP, 8-K, 2001-01-16



<TABLE> <S> <C>

<ARTICLE>                                       5


<S>                                                   <C>
<PERIOD-TYPE>                                       3-MOS
<FISCAL-YEAR-END>                                   MAY-31-2001
<PERIOD-END>                                        NOV-30-2000
<CASH>                                                  3195038
<SECURITIES>                                                  0
<RECEIVABLES>                                          21212028
<ALLOWANCES>                                                  0
<INVENTORY>                                            18921501
<CURRENT-ASSETS>                                       47242236
<PP&E>                                                 25848394
<DEPRECIATION>                                          8997775
<TOTAL-ASSETS>                                        103413382
<CURRENT-LIABILITIES>                                  25230304
<BONDS>                                                36938896
                                         0
                                                   0
<COMMON>                                                 727762
<OTHER-SE>                                             36879670
<TOTAL-LIABILITY-AND-EQUITY>                          103413382
<SALES>                                                16813264
<TOTAL-REVENUES>                                       16813264
<CGS>                                                   8839249
<TOTAL-COSTS>                                           8839249
<OTHER-EXPENSES>                                        7580845
<LOSS-PROVISION>                                              0
<INTEREST-EXPENSE>                                       814026
<INCOME-PRETAX>                                         (361973)
<INCOME-TAX>                                             250276
<INCOME-CONTINUING>                                     (612249)
<DISCONTINUED>                                                0
<EXTRAORDINARY>                                               0
<CHANGES>                                                     0
<NET-INCOME>                                            (612249)
<EPS-BASIC>                                               (0.08)
<EPS-DILUTED>                                             (0.08)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission